All Press Releases
PILA PHARMA erhåller GMP-certifiering av placebo-tabletter
Malmö, 14 september, 2021 Läs pressmeddelandet som PDF här PILA PHARMA AB (publ) (”PILA PHARMA” eller ”Bolaget”) meddelar att de placebo-tabletter som ska användas i kommande kliniska studier är tillverkade och GMP-certifierade (Good Manufacturing Process). Placebo-tabletter är en nyckelkomponent i de flesta kliniska studier för att säkerställa en hög nivå på resultatens reliabilitet. Redan i juni 2021 erhöll Bolaget GMP-certifiering…
PILA PHARMA recieves GMP certification of placebo tablets
Malmö, Sweden, 14 september, 2021 Read the press release as a PDF here PILA PHARMA AB (publ) (“PILA PHARMA” or “the Company”) announces that the placebo tablets to be used in coming clinical studies have now been manufactured, and GMP (Good Manufacturing Practice) certified. Placebo tablets are a key component of most clinical trials, in order to ensure a high…
PILA PHARMA AB, announces API manufacturing agreement signed
Malmö, Sweden, 05 August 2021 Read the press release as a PDF here PILA PHARMA AB (PILA) today announces signing of a manufacturing agreement with Almac Sciences Limited, UK, for the production of XEN-D0501 active pharmaceutical ingredient (API). The availability of new API is key for conducting the planned 3 month toxicology studies, that are in turn a prerequisite for…